Prostanoid function and cardiovascular disease

Prostanoid function and cardiovascular disease

Item
http://www.wikidata.org/entity/Q58869382
Prostaglandin I2 signaling drives Th17 differentiation and exacerbates experimental autoimmune encephalomyelitis.Gender differences in cardiovascular disease: hormonal and biochemical influences.A Double Whammy: Targeting Both Fatty Acid Amide Hydrolase (FAAH) and Cyclooxygenase (COX) To Treat Pain and Inflammation.Prostanoids receptors signaling in different diseases/cancers progression.Identification of hypertrophy- and heart failure-associated genes by combining in vitro and in vivo models.Platelet-targeted pharmacologic treatments as anti-cancer therapy.Lipopolysaccharide induces H1 receptor expression and enhances histamine responsiveness in human coronary artery endothelial cells.Comparison of UHPLC and HPLC methods for the assay of prostanoids: "are the methods equivalent in terms of accuracy and precision?".Knockout of the Prostaglandin E2 Receptor Subtype 3 Promotes Eccentric Cardiac Hypertrophy and Fibrosis in Mice.
P2860

Prostanoid function and cardiovascular disease

Item
http://www.wikidata.org/entity/Q58869382
description
im Juli 2008 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 July 2008
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 2008
@uk
name
Prostanoid function and cardiovascular disease
@en
Prostanoid function and cardiovascular disease
@nl
type
label
Prostanoid function and cardiovascular disease
@en
Prostanoid function and cardiovascular disease
@nl
prefLabel
Prostanoid function and cardiovascular disease
@en
Prostanoid function and cardiovascular disease
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Prostanoid function and cardiovascular disease
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921